Dyslipoproteinemia in black participants. The Lipid Research Clinics Program Prevalence Study. 1986

T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler

A comparison of blacks and whites 6 to 49 years old revealed striking differences between races with respect to the prevalence of various dyslipoproteinemias and mean plasma lipid levels. Compared with whites, juvenile and adult blacks of both sexes had higher mean levels of high-density lipoprotein cholesterol (HDL-C), with correspondingly higher prevalences of the hyperHDL and hypoLDL (low-density lipoprotein) phenotypes. In contrast, whites showed a much higher prevalence of type IV hyperlipoproteinemia and higher mean triglyceride levels in most age-sex groups. Although juvenile blacks had higher mean levels of LDL-C than did whites, this race difference was reversed in men, while women showed inconsistent differences between races. Adult black men and juvenile blacks of both sexes had a somewhat higher prevalence of the type IIA phenotype than whites. The distribution of major HDL-C predictors in this population could not account for the difference in prevalence of hyperHDL between races. These findings suggest that health professionals may find differences in plasma lipid and lipoprotein patterns between their black and white patients, but additional research is needed to ascertain the disease risks associated with dyslipoproteinemia among blacks.

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D007009 Hypolipoproteinemias Conditions with abnormally low levels of LIPOPROTEINS in the blood. This may involve any of the lipoprotein subclasses, including ALPHA-LIPOPROTEINS (high-density lipoproteins); BETA-LIPOPROTEINS (low-density lipoproteins); and PREBETA-LIPOPROTEINS (very-low-density lipoproteins). Hypolipoproteinemia,Hypoprebetalipoproteinemia
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol

Related Publications

T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler
January 1986, Circulation,
T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler
January 1986, Circulation,
T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler
January 1986, Circulation,
T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler
January 1986, Circulation,
T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler
November 1980, Circulation,
T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler
January 1986, Circulation,
T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler
January 1986, Circulation,
T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler
May 1990, Circulation,
T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler
January 1986, Circulation,
T C Wilcosky, and P O Kwiterovich, and C J Glueck, and C M Suchindran, and P Laskarzewski, and B Christensen, and H A Tyroler
January 1986, Atherosclerosis,
Copied contents to your clipboard!